Correlation Between Silo Pharma and Nascent Biotech

Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Nascent Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Nascent Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silo Pharma and Nascent Biotech, you can compare the effects of market volatilities on Silo Pharma and Nascent Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Nascent Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Nascent Biotech.

Diversification Opportunities for Silo Pharma and Nascent Biotech

0.24

Correlation Coefficient

Silo Pharma  Nascent Biotech

Modest diversification

The 3 months correlation between Silo and Nascent is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Nascent Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nascent Biotech and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Nascent Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nascent Biotech has no effect on the direction of Silo Pharma i.e., Silo Pharma and Nascent Biotech go up and down completely randomly.

Pair Corralation between Silo Pharma and Nascent Biotech

Given the investment horizon of 90 days Silo Pharma is expected to under-perform the Nascent Biotech. But the otc stock apears to be less risky and, when comparing its historical volatility, Silo Pharma is 2.35 times less risky than Nascent Biotech. The otc stock trades about -0.01 of its potential returns per unit of risk. The Nascent Biotech is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  4.60  in Nascent Biotech on September 3, 2024 and sell it today you would earn a total of  1.58  from holding Nascent Biotech or generate 34.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.46%
Values	Daily Returns

Silo Pharma  vs.  Nascent Biotech

Silo Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Silo Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Nascent Biotech

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nascent Biotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Nascent Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Silo Pharma and Nascent Biotech

The main advantage of trading using opposite Silo Pharma and Nascent Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Nascent Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nascent Biotech will offset losses from the drop in Nascent Biotech's long position.

The idea behind Silo Pharma and Nascent Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.